Prednisolone acetate
- Generic Name
- Prednisolone acetate
- Brand Names
- Blephamide, Econopred Plus, Flo-pred, Pred Forte, Pred Mild, Pred-G
- Drug Type
- Small Molecule
- Chemical Formula
- C23H30O6
- CAS Number
- 52-21-1
- Unique Ingredient Identifier
- 8B2807733D
- Background
Prednisolone acetate is a prednisolone molecule bound to an acetate functional group by an ester bond.
Prednisolone acetate was granted FDA approval in 1955.
- Indication
Prednisolone acetate is indicated as an anti-inflammatory or immunosuppressive agent for allergic, dermatologic, gastrointestinal, hematologic, ophthalmologic, nervous system, renal, respiratory, rheumatologic, or infectious conditions. Prednisolone acetate is also indicated in organ transplant patients, as well as endocrine or neoplastic conditions.
- Associated Conditions
- Inflammation, Inflammatory Conditions, Ocular Infections, Irritations and Inflammations, Ocular Inflammation, Transplanted Organ Rejection
- Associated Therapies
- -
Study of T-PRED(TM) Compared to Pred Forte(R) II
- First Posted Date
- 2009-03-02
- Last Posted Date
- 2020-10-20
- Lead Sponsor
- Bausch & Lomb Incorporated
- Target Recruit Count
- 172
- Registration Number
- NCT00854061
- Locations
- 🇺🇸
ISTA Pharmaceuticals, Inc., Irvine, California, United States
Determination of Optimum Duration of Treatment With Bromfenac (Xibrom) Eyedrops Following Cataract Surgery
- Conditions
- Interventions
- First Posted Date
- 2008-09-25
- Last Posted Date
- 2012-03-15
- Lead Sponsor
- Bp Consulting, Inc
- Target Recruit Count
- 49
- Registration Number
- NCT00758199
- Locations
- 🇺🇸
Altos Eye Physicians, Los Altos, California, United States
Study of T-PRED(TM) Compared to Pred Forte(R)
- First Posted Date
- 2008-06-18
- Last Posted Date
- 2020-09-25
- Lead Sponsor
- Bausch & Lomb Incorporated
- Target Recruit Count
- 64
- Registration Number
- NCT00699803
- Locations
- 🇺🇸
ISTA Pharmaceuticals, Inc., Irvine, California, United States
Study of Difluprednate in the Treatment of Uveitis
- Conditions
- First Posted Date
- 2007-07-16
- Last Posted Date
- 2008-08-29
- Lead Sponsor
- Sirion Therapeutics, Inc.
- Registration Number
- NCT00501579
- Locations
- 🇺🇸
John-Kenyon American Eye Institute, New Albany, Indiana, United States
To Study the Effectiveness and Safety of Niacin and a Topical Steroid Eye Drop to Treat Retinal Vein Occlusions
- Conditions
- Interventions
- First Posted Date
- 2007-06-27
- Last Posted Date
- 2018-12-21
- Lead Sponsor
- Palo Alto Medical Foundation
- Target Recruit Count
- 63
- Registration Number
- NCT00493064
- Locations
- 🇺🇸
Palo Alto Medical Foundation Department of Ophthalmology, Palo Alto, California, United States
Comparing Acular LS and Pred Forte in Reducing Post-selective Laser Trabeculoplasty Anterior Chamber Flare and Cells
- Conditions
- Interventions
- First Posted Date
- 2007-05-24
- Last Posted Date
- 2016-10-07
- Lead Sponsor
- University of Colorado, Denver
- Target Recruit Count
- 31
- Registration Number
- NCT00478036
- Locations
- 🇺🇸
University of Colorado Eye Center, Aurora, Colorado, United States
Efficacy of Topical Ketorolac Versus Placebo for Improving Visual Outcomes Following Multifocal IOL Implantation
- Conditions
- First Posted Date
- 2007-02-09
- Last Posted Date
- 2007-09-10
- Lead Sponsor
- Innovative Medical
- Registration Number
- NCT00433225
- Locations
- 🇺🇸
Ophthalmic Consultants of Long Island, Rockville Centre, New York, United States
Therapeutic Variables in Cataract Surgery
- Conditions
- First Posted Date
- 2006-12-04
- Last Posted Date
- 2007-08-21
- Lead Sponsor
- Innovative Medical
- Registration Number
- NCT00407017
- Locations
- 🇺🇸
The Center for Excellence in Eye Care, Miami, Florida, United States
A Comparison of Three Different Formulations of Prednisolone Acetate 1%
- Conditions
- Interventions
- First Posted Date
- 2006-06-27
- Last Posted Date
- 2015-06-03
- Lead Sponsor
- Indiana University School of Medicine
- Target Recruit Count
- 60
- Registration Number
- NCT00345046
- Locations
- 🇺🇸
IU Eye at Carmel, Indianapolis, Indiana, United States
A Study to Compare Ocular Safety and Tolerability of Eye Drops Containing Prednisolone Acetate in Patients With Intraocular Inflammation After Cataract Surgery
- Conditions
- First Posted Date
- 2005-09-15
- Last Posted Date
- 2017-03-01
- Lead Sponsor
- Novartis
- Target Recruit Count
- 62
- Registration Number
- NCT00170729
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.